Y-mAbs Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 44.6M shares, a 2.31% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 43.6M shares, a 0.13% decline from 2022.
  • Y-mAbs Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 43.7M shares, a 1.21% increase from 2021.
  • Y-mAbs Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 43.2M shares, a 7.64% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 44.6M +1.01M +2.31% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 44M +359K +0.82% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 43.8M +108K +0.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 43.6M -58.3K -0.13% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 43.6M -97.8K -0.22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 43.7M -55.6K -0.13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 43.7M -37.6K -0.09% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 43.7M +522K +1.21% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 43.7M +120K +0.28% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 43.7M +149K +0.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 43.7M +1.84M +4.39% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 43.2M +3.06M +7.64% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 43.6M +3.41M +8.49% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 43.6M +3.6M +9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 41.9M +2.12M +5.33% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 40.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 40.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 40M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 39.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.